Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMedicus Pharma Ltd. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q2 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q3 2025 | 2 | -$1.04 | -$0.85 | -$0.95 |
| Q4 2025 | 2 | -$0.26 | -$0.20 | -$0.23 |
| Q1 2026 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q2 2026 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q3 2026 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q4 2026 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q1 2027 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2027 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2027 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2027 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q1 2028 | 1 | $0.11 | $0.11 | $0.11 |
| Q2 2028 | 1 | $0.11 | $0.11 | $0.11 |
| Q3 2028 | 1 | $0.11 | $0.11 | $0.11 |
| Q4 2028 | 1 | $0.12 | $0.12 | $0.12 |
Medicus Pharma Ltd. Common Stock Earnings Date And Information
Medicus Pharma Ltd. Common Stock last posted its earnings results on Friday, November 14th, 2025. The company reported $-0.65 earnings per share for the quarter, missing analysts' consensus estimates of $-0.38 by $0.27. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Medicus Pharma Ltd. Common Stock has generated $-1 earnings per share over the last year ($-1.1 diluted earnings per share) and currently has a price-to-earnings ratio of -2.64. Medicus Pharma Ltd. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 27th, 2026 based on prior year's report dates.
Medicus Pharma Ltd. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2025 | Q3 2025 | -$0.38 | -$1.12 | -0.74 | $0 | $0 |
| 08/11/2025 | Q2 2025 | -$0.39 | -$0.43 | -0.04 | $0 | $0 |
| 05/12/2025 | Q1 2025 | -$0.23 | -$0.42 | -0.19 | $0 | $0 |
| 04/30/2025 | Q4 2024 | N/A | -$0.24 | N/A | $0 | $0 |
| 11/25/2024 | Q3 2024 | N/A | -$0.31 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.51 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.22 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | -$0.30 | -$1.41 | -1.11 | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$1.47 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$0.06 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Medicus Pharma Ltd. Common Stock Earnings: FAQ's
Medicus Pharma Ltd. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 27th, 2026 based offlast year's report dates.
The conference call for Medicus Pharma Ltd. Common Stock's latest earnings report can be listened to online.
The conference call transcript for Medicus Pharma Ltd. Common Stock's latest earnings report can be read online.
Medicus Pharma Ltd. Common Stock (:MDCX) has a recorded net income of $-11,155,516.Medicus Pharma Ltd. Common Stock has generated $-1.1 earnings per share over the last four quarters.
Medicus Pharma Ltd. Common Stock (:MDCX) has a price-to-earnings ratio of -2.64 and price/earnings-to-growth ratio is 0.05.